Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
Furosemide
8%
4/49
Chronic renal failure
39%
19/49
Glyburide
4%
2/49
Renal tubular acidosis
45%
22/49
Amlodipine
0%
0/49
Select Answer to see Preferred Response
This diabetic with a non-anion gap metabolic acidosis (AG = 138-(112+18)=8, normal 6-12), hyperkalemia, and renal insufficiency should be suspected of having type 4 renal tubular acidosis (RTA). Type 4 RTA is caused by either a deficiency of aldosterone or decreased sensitivity of the renal tubules to aldosterone. The lack of effect of aldosterone leads to decreased secretion of acid as ammonium (NH4+) and retention of potassium. Type 4 RTA may occur in the setting of diabetic nephropathy and can be exacerbated by drugs that inhibit the renin-angiotensin-aldosterone system, such as ACE inhibitors or ARBs. Illustration A summarizes the characteristics of the different types of RTA. Illustration B lists a number of medications associated with RTA. Incorrect Answers: Answer 1: Furosemide is a loop diuretic that may cause contraction alkalosis due to hypovolemia, which would cause a primary increase in bicarbonate. Answer 2: Chronic renal failure can cause anion-gap metabolic acidosis due to failure to excrete acid as NH4+. Answer 3: Glyburide is a sulfonylurea hypoglycemic drug that can cause hypoglycemia, but is not associated with acid-base disturbances. Answer 5: Amlodipine is a calcium channel blocker that is not associated with acid-base disturbances.
4.8
(4)
Please Login to add comment